ISPOR Europe 2025 witnessed a strategic partnership to elevate Global HTA with popular AI

Announcement

Cliniphai, a leading Framework platform and AI Agent, an intentional source to resolve the issues regarding life sciences, has entered a smart collaboration with Nested Knowledge, a key player in evidence review technology. Together, the companies will begin to leverage and streamline the submission and preparation of general Health Technology Assessment (HTA) dossiers worldwide. The collaboration was uniformed at the ISPOR Europe 2025 conference held at the Scottish Event Campus in Glasgow this week.

This partnership will merge Cliniphai’s basic leading regular platform, Athena and its smart partner Gibson Research Consultancy (GRC). This integrative partnership will strengthen this new partnership and double the previous profit that Cliniphai has experienced long time. GRC is a leader ruling worldwide in user-centred research and linguistic validation to serve AI-powered human-in-the-loop (HITL) translations of dossier components to the desk of Nested Knowledge’s comprehensive, systematic, proven synthesis platform.

Purpose-built partnership

With the support of GRC, these companies are solving a crucial congestion in HTA dossier generalisation by serving continuous adaptation of HTA dossiers, expert-led HITL translations, AI-enabled evidence synthesis, enhanced compliance and accuracy. The AI-enabled evidence synthesis will be delivered via Nested Knowledge’s indirect treatment and sophisticated literature review, proven to be excellent in comparison to tools. The quick consistency adaptation of HTA dossiers will serve the needs of the health authorities globally.

Via operational visibility and built-in regulatory adherence, the compliance and accuracy will be sharpened. GRC-vetted linguistics and Cliniphai’s Athena platform provide specialised HITL expert-led translations. The collaboration identifies the time stress and the complexity of fostering the robust HTA dossiers for various local language and regulatory bodies globally.

The companies will massively improve the rooted evidence synthesis (SLRs and ICTs) via accelerating the machine learning and AI potential of the Nested Knowledge platform. Then, after this tech integration, Cliniphai will use its platform to connect a network of GRC-vetted local regulatory and skilled linguistic experts to promise compliant, accurate and rapid localisation of these critical documents.

The MS, co-founder and Chairman at Cliniphai, Jason Martin, said, “Our main motive is to support our clients to leverage study start-up activities and serve the required therapies to the patient population globally. Collaborating with Nested knowledge enables us to alleviate the time needed to translate clinical proven into an HTA submission and embed them for numerous global requirements, using our compliant GRC hired talent model.”